Element List	Explanation
Introduction	Professional Medical Expertise Company (“ProMedEx”) announces the Board of Directors’ recommendation to increase the Company’s share capital by SAR 70,000,000 through a rights issue (“Rights Offering”), to finance its growth plans aimed at diversifying its product portfolio.
Date of Board Meeting	2025-10-01 Corresponding to 1447-04-09
Target Amount	70,000,000 SAR
Reasons for the increase	The rights issue offering enables ProMedEx to support its strategic plans, which include expanding its agency network, investing in the manufacturing of new products, and supporting the development of the company's future activities
Eligibility date	Shareholders holding shares on the date of the Extraordinary General Assembly meeting in which capital increase through the issuance of right issues was resolved whose names so appear in the register of the Issuer’s Shareholders at the Depository Center at the end of the second trading day following the date of the General Assembly’s Meeting.
Approvals	The Board’s recommendation is subject to the approval of the relevant regulatory authorities and ProMedEx’s shareholders at the EGM
Appointment of Financial Advisor and Submission of the Capital Increase Application File to CMA	Alistithmar for Financial Securities and Brokerage Company ("Alistithmar Capital") has been appointed as the financial advisor for the capital increase process
Additional Information	The date of submitting the capital increase application file to the Capital Market Authority, along with any future developments in this regard, will be announced in due course